https://www.selleckchem.com/pr....oducts/Enzastaurin.h
5%, 26.7%, 93.7%, and 36.5%, respectively. BV and RCVs were firstly established for 8-oxo-dGsn and 8-oGsn, and can be used in clinical practice. BV and RCVs were firstly established for 8-oxo-dGsn and 8-oGsn, and can be used in clinical practice.A highly nucleobase-discriminating metalated nucleoside analogue, 3-fluoro-2-mercuri-6-methylaniline, was incorporated into an oligonucleotide molecular beacon. Fluorescence emission spectra were measured after the addition of four different complementary strands, in which the nucleobase opp
Like
Comment
Share
